Sponsor Dossier
Generic Health
Sponsor Dossier for Generic Health. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ACTOS
- Brand: ALENDROBELL
- Brand: ALFENTANIL GH
- Brand: AMLODIPINE GH
- Brand: AMOXYCLAV GENERICHEALTH
- Brand: ANASTROZOLE-GH
- Brand: ARIPIPRAZOLE GH
- Brand: ATENOLOL
- Device (sponsor): Clinical chemistry hormone IVDs
About
Generic Health is an Australian Private Company with ABN 93110617859, incorporated in Victoria. The company is registered for GST and maintains active entity status. Generic Health operates under the trading name LUPIN au.
Portfolio
Generic Health maintains a portfolio of 60 brands on the ARTG, with 50 indexable brands and 49 with Product Information on file. Five brands are PBS-listed, three brands have PBAC outcomes on record, and one brand has an AusPAR on record.
Therapeutic focus The portfolio spans fifteen therapeutic areas as follows:
— Neurology: 18 brands — Cardiology: 8 brands — Infectious Disease: 7 brands — Gastroenterology: 5 brands — Endocrinology: 4 brands — Oncology: 4 brands — Pain & Anaesthesia: 3 brands — Respiratory: 2 brands — Urology: 2 brands — Dermatology: 2 brands — Immunology: 1 brand — Rare Disease: 1 brand — Women's Health: 1 brand — Reproductive Health: 1 brand — Pain Management: 1 brand
PBS footprint
Generic Health has five brands with at least one PBS-listed item, with the portfolio's latest PBS schedule date being 1 May 2026.
Regulatory activity
The most recent PBAC outcome for Generic Health was dated 1 November 2023, with three brands holding PBAC outcomes on record. The most recent AusPAR was dated 20 March 2023, with one brand holding an AusPAR on record.